Laserfiche Recognized as a Leader in 2024 Gartner ® Magic Quadrant™ for Document Management
Laserfiche — a leading enterprise platform that helps organizations manage their most critical content and workflows — has been positioned as a Leader in the 2024 Magic Quadrant for Document Management. Laserfiche was recognized by Gartner based on its completeness of vision and ability to execute.
“We’re excited to be named a Leader in the new document management report along with being recognized as a Gartner Peer Insights Customers’ Choice earlier this year,” said Thomas Phelps, CIO and SVP of corporate strategy at Laserfiche. “With customers around the world using Laserfiche to manage their content and scale their business, we are relentlessly focused on product innovation and an outstanding customer experience.”
In the 2024 Magic Quadrant for Document Management report, Laserfiche was positioned furthest to the right for Completeness of Vision in the Leaders quadrant.
“The City of Los Angeles is a top Digital City in the U.S., a testament to our commitment to delivering digitally advanced services to our constituents,” said Ted Ross, CIO of the City of Los Angeles. “Partnerships with leading technology providers like Laserfiche support our vision for continuous digital transformation and enable us to provide the best possible government experience for all Angelenos.”
“The California State University is the nation’s largest public four-year university system with 23 campuses and over 470,000 students,” said Ed Clark, CIO at the California State University Office of the Chancellor. “Laserfiche has been key to our focus on efficiency and innovation in areas such as contract management.”
Managing Unstructured Data and Powering Content-Centric Workflows
An estimated 70-80% of the world’s data is unstructured. Laserfiche helps organizations manage their data silos and provides an enterprise platform for workflow automation, information governance and records management.
With Laserfiche, organizations can take advantage of core product capabilities to:
- Optimize workflows and business processes: With Laserfiche Workflow, organizations can automate content-centric processes and integrate with enterprise applications.
- Accelerate human productivity: Organizations can enhance productivity through solution templates, generative AI tools and other intelligent services.
- Enforce information governance: To help address growing regulatory requirements for storing and handling sensitive data, Laserfiche provides robust security tools for content sharing, user activity auditing and records management.
Create Business Value from Software that People Love to Use
Gartner® Peer Insights™ captures customer experience with Gartner-verified ratings and reviews. As of November 11, 2024, Laserfiche reviews include the following:
- “We love Laserfiche. It's so much more user friendly than our previous solution and is much more scalable to our size.” — Core IT Systems Manager, banking industry [read full review]
- “I LOVE Laserfiche!!! I am still new at understanding its capability, but I am amazed at how many areas of our business functions this can touch and improve.” — CFO, education industry [read full review]
- “From business process automation to overall records management, this software has been a lifesaver for our county office of education. The product is robust, scalable and innovative.” — Executive Director of HR & Business Administration [read full review]
- “Laserfiche is an incredibly robust Forms solution that allows us to provide innovative automated processes and to improve existing legacy business processes. We have been thrilled with this product.” — IT manager, healthcare and biotech industry [read full review]
For More Information
- Download a complimentary copy of the report, 2024 Gartner® Magic Quadrant™ for Document Management.
- Learn why Laserfiche was named as a 2024 Customers’ Choice for Content Services Platform in 2024 Gartner® Peer Insights Voice of the Customer for Content Services Platforms.
- See how the Motion Picture Industry Pension & Health Plans uses Laserfiche to support its plan participants.
Gartner Disclaimers
Gartner Peer Insights content consists of the opinions of individual end users based on their own experiences, and should not be construed as statements of fact, nor do they represent the views of Gartner or its affiliates. Gartner does not endorse any vendor, product or service depicted in this content nor makes any warranties, expressed or implied, with respect to this content, about its accuracy or completeness, including any warranties of merchantability or fitness for a particular purpose.
GARTNER is a registered trademark and service mark of Gartner, Inc. and/or its affiliates in the U.S. and internationally, and PEER INSIGHTS and MAGIC QUADRANT is a registered trademark of Gartner, Inc. and/or its affiliates and are used herein with permission. All rights reserved.
About Laserfiche
Laserfiche is a leading enterprise platform for document management and content-centric workflow automation. Through scalable workflows, forms, no-code templates and AI-enabled capture, the Laserfiche® platform accelerates how business gets done.
Laserfiche pioneered the paperless office with enterprise content management. Today, Laserfiche’s cloud-first development approach incorporates innovations in machine learning and AI to enable organizations globally to transform into digital businesses. Customers in every industry — including government, education, financial services, healthcare and manufacturing — use Laserfiche to boost productivity, scale their business and deliver digital-first customer experiences.
Laserfiche employees are committed to the company’s vision of empowering customers and inspiring people to reimagine how technology can transform lives.
Connect with Laserfiche:
Laserfiche Blog | X | LinkedIn | Facebook
View source version on businesswire.com: https://www.businesswire.com/news/home/20250107763038/en/
Contacts
Media Contact:
Linda Domingo
Communications Director, Laserfiche
Linda.domingo@laserfiche.com
562-988-1688 ext. 234
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Aspect Announces CEO Leadership Transition and New Independent Board7.1.2026 01:13:00 EET | Press release
Aspect, a leading provider of cloud-based workforce management solutions, has announced a leadership transition, including the appointment of Jeff Kupietzky as Interim Chief Executive Officer and the formation of a new independent Board of Directors, marking an important next chapter for the company. As part of this transition, Darryl Kelly will step down as Chief Executive Officer and transition into a Strategic Advisor role, effective January 1, 2026. Darryl led Aspect through a pivotal period of transformation, helping reposition the business, refine its vision, and reinvigorate its innovation and execution. The company and its stakeholders thank Darryl for his leadership and contributions during a period of meaningful change. With Darryl continuing as Strategic Advisor, the organization retains continuity for employees, customers, and stakeholders. “Aspect is starting a new season, building upon the strong foundation we’ve created together,” said Darryl Kelly. “This transition is a
Brenus Pharma Reports Favorable Tolerability and Clinical Signals in Early Preliminary Results of First-In-Human Study for STC-1010 in Unresectable Metastatic Stage Colorectal Cancer (MSS CRC) Patients6.1.2026 22:00:00 EET | Press release
Brenus Pharma, a clinical stage biotechnology company unlocking the immune system in vivo to fight solid tumors, announced the successful completion of the first dose levels in its ongoing first-in-human study. The multi-center, open-label trial (NCT06934538) is a phase Ia/Ib study designed to evaluate safety, tolerability and preliminary clinical activity of STC-10101 in a first line setting. It will include in vivo analysis of immune and tumor dynamics during dose escalation of treatment and cohort extension to patients with unresectable locally advanced (stage IIIC, T4b) or unresectable metastatic (stage IV) MSS2 colorectal cancer (CRC). Early findings indicate that the first dose levels have been successfully completed with good overall tolerance and no-dose-limiting toxicities observed to date. “We are pleased to report that the safety profile observed to date is good and consistent with our expectations with no DLT,” said Paul Bravetti, CEO of Brenus Pharma. “Moreover, preliminar
SPIE, the International Society for Optics and Photonics, Announces Its 2026 Fellows6.1.2026 21:35:00 EET | Press release
SPIE, the international society for optics and photonics, welcomes 40 Members as new Fellows of the Society in the 2026 cohort. They join their Fellow Member colleagues in being honored for their excellent technical achievements, as well as for their substantial service to the optics and photonics community and to SPIE. Fellows are Members of the Society who have made significant scientific and technical contributions in the multidisciplinary fields of optics, photonics, and imaging. Since the Society's inception in 1955, more than 1,800 SPIE Members have become Fellows. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260106630672/en/ SPIE, the international society for optics and photonics, announces its 2026 Fellows This year’s inductees are high-profile leaders in academia, industry, and government, many of whom are particularly prominent in their support of the optics and photonics community and mentorship of others. “It’
Chemelex Adds Electric Heat Trace Group Ltd.’s SmartTrace Monitoring Platform to its Heat Tracing Portfolio6.1.2026 21:00:00 EET | Press release
Chemelex, a global leader in electric thermal and sensing solutions, today announced the successful completion of its acquisition of substantially all the assets and ongoing operations of Electric Heat Trace Group Ltd. (EHT Group), headquartered in Ontario, Canada. This strategic move marks an exciting start to the new year and reinforces Chemelex’s commitment to delivering smarter, data-driven solutions for industrial heat trace systems. EHT Group is a recognized innovator in heat trace management, offering advanced software, integrated controller solutions, wireless communication modules, and comprehensive field services. Its flagship platform, SmartTrace, is a robust solution available in both cloud-based and on-premises deployments that enables predictive maintenance, minimizes downtime, and provides secure remote monitoring—helping customers achieve greater reliability and operational efficiency. This endeavor will help Chemelex support greater operational efficiencies for our cus
ZIIHERA Plus TEVIMBRA and Chemotherapy: A Potential New Standard for First-Line HER2+ Advanced GEA6.1.2026 20:30:00 EET | Press release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced full results from the Phase 3 HERIZON-GEA-01 trial evaluating ZIIHERA® (zanidatamab), a HER2-targeted bispecific antibody, in combination with chemotherapy, with and without PD-1 inhibitor TEVIMBRA® (tislelizumab), as a first-line treatment for HER2-positive (HER2+) locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). These data, including the first interim overall survival (OS) analysis, will be presented as a Late-Breaking Abstract Oral Presentation (#LBA285) at the American Society of Clinical Oncology Gastrointestinal Cancers Symposium (ASCO GI) on January 8, 2026, from 8:57- 9:07 a.m. PST. HERIZON-GEA-01 met the dual primary endpoint of progression-free survival (PFS), demonstrating statistically significant and clinically meaningful improvements in both experimental arms compared to the control arm. The addition of TEVIMBRA to ZIIHERA and chemotherapy also sho
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom